Latest news
Why Zevra Therapeutics (ZVRA) Is Up 21.6% After Strong MIPLYFFA Uptake And New Real-World Data - simplywall.stsimplywall.st · Sat, 08 Aug 2026 10:47:29 GMTZVRA Stock Hits Its Highest Levels In Nearly 5 Years – What’s Driving This Sharp Rally Today? - StocktwitsStocktwits · Sat, 08 Aug 2026 07:01:13 GMTMaxim Group Maintains Zevra Therapeutics(ZVRA.US) With Buy Rating, Maintains Target Price $35 - MoomooMoomoo · Sat, 08 Aug 2026 04:10:38 GMTZevra Therapeutics, Inc. (ZVRA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS NewswireACCESS Newswire · Fri, 07 Aug 2026 20:19:32 GMTsymbol__ Stock Quote Price and Forecast - CNNCNN · Fri, 07 Aug 2026 11:33:13 GMTWhat Could Zevra Therapeutics (ZVRA) New NPC Data Mean For Its Europe Review? - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 05:12:00 GMTINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zevra Therapeutics, Inc. - ZVRA - PR NewswirePR Newswire · Fri, 07 Aug 2026 03:02:00 GMTZevra Therapeutics (ZVRA) Stock Jumps On Profitability While MIPLYFFA Concentration Lingers - simplywall.stsimplywall.st · Fri, 07 Aug 2026 02:18:50 GMT